Trials / Enrolling By Invitation
Enrolling By InvitationNCT06931886
Pulmonary Hypertension Inspiratory Training
Effects of Inspiratory Muscle Strength Training on Pulmonary Hypertension: A Six Week Study
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (estimated)
- Sponsor
- University of Arizona · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is examining the effects of six weeks of inspiratory muscle strength training (IMST) on outcomes related to pulmonary hypertension. This study leverages previous cardiopulmonary exercise test (CPET) results and a pre-existing upcoming CPET to examine the effects of IMST on cardiopulmonary pressures and exercise tolerance and ability.
Detailed description
PH is a condition characterized by abnormally high blood pressure in the lungs (i.e., pulmonary arterial pressure), which impacts heart function and reduces exercise tolerance. This study will assess whether six weeks of a breathing exercise called IMST can improve heart and lung function as well as exercise capacity for individuals with PH. For this study, patients will be asked to perform IMST for the six weeks prior to their next scheduled clinical standard of care assessment of their PH. The goal of this study is to determine whether IMST reduces pulmonary arterial pressure and improves exercise tolerance in individuals with PH. This study will be minimally invasive, as it simply adds a safe, well-tolerated, non-invasive respiratory training to the participants' standard of care and leverages their existing PH assessment data to evaluate the impact of IMST on PH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Inspiratory Muscle Strength Training | Participants will be asked to inhale against a resistance. This resistance will be set to \~55% of their maximal inspiratory ability. Participants will complete 5 sets of 6 breaths (30 total) a day for 5 days a week for 6 weeks. |
Timeline
- Start date
- 2025-10-25
- Primary completion
- 2026-05-01
- Completion
- 2026-10-01
- First posted
- 2025-04-17
- Last updated
- 2025-12-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06931886. Inclusion in this directory is not an endorsement.